Healthcare
Terveystalo Oyj(TTALF)
Live Price
Offline$8.95
+0.00% today
1Y Change
-30.89%
Window
Jun 23, 2025 โ Jun 17, 2026
- Market Cap
- $990.00M
- Revenue Growth
- -4.6%
- EPS Growth
- +28.1%
- Dividend Yield
- 7.2%
Coverage: 254 bars ยท Jun 23, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Terveystalo Oyj (TTALF) is a Healthcare stock with a market cap of $990.00M and listed on OTC. The stock last traded around $8.95 and down 30.9% across the available one-year price window (Jun 23, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of -4.6%, EPS growth of +28.1%, a dividend yield of 7.2%. What stands out right now is revenue -4.6%, EPS +28.1%, free cash flow -15.1% with operating margin 9.3% and ROIC 7.9%. The dividend matters to the case here, with a current yield around 7.2%. Valuation is more restrained than many high-expectation growth names at P/E 13.0 and price/sales 0.8. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines TTALF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-4.6% vs +7.6% peer median
Operating Margin
Below sector median
+9.3% vs +19.4% peer median
P/E
Below sector median
13.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 24, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -4.6% and EPS is at +28.1%, with operating margin around 9.3%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 7.2%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 24, 2026 | โ | +0.0% | +0.0% | +0.0% |
2026 Feb 13, 2026 | -35.6% | +0.0% | +0.0% | -30.9% |
2025 Oct 23, 2025 | -7.0% | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TTALF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TTALF Max Drawdown
-30.89%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TTALF and SPY.
Company Overview
Terveystalo Oyj
Other OTC
Terveystalo Oyj provides occupational healthcare services in Finland. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; and outsourcing services, staffing services, child welfare services, oral health, laboratory, imaging, wellbeing, day surgery, healthcare outsourcing, healthcare staffing, and primary and specialty care services. It also provides a suite of digital healthcare services; and clinical research services. The company serves private individuals, companies and communities, insurance companies, and public sector customers. It operates 360 clinics, which include 18 hospital units and 38 dental clinics; and 73 Rela hierojat massage therapy units. The company was founded in 2001 and is based in Helsinki, Finland.
- Leadership
- Ville Iho
- IPO Date
- Jun 25, 2018
- Employees
- 8.4k
- Street Address
- Jaakonkatu 3 A
- Mailing
- Helsinki, 00100
- Region
- Helsinki, FI
- Reporting Currency
- USD
- Investor Line
- 358 0306 3311
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 13.0
- EV/EBITDA
- 7.0
- Price/Sales
- 0.8
- Price/Book
- 1.9
Growth
- Revenue
- -4.6%
- EPS
- +28.1%
- Free Cash Flow
- -15.1%
Profitability
- Gross Margin
- 30.5%
- Operating Margin
- 9.3%
- Net Margin
- 6.2%
- ROE
- 13.8%
- ROIC
- 7.9%
Balance Sheet
- Debt/Equity
- 1.17
- Current Ratio
- 0.54
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.